ABUS vs ABL

Comparison between Arbutus Biopharma Corp (ABUS, Company) and Abacus Global Management Inc. (ABL, Company).

ABUS is from the Healthcare sector, while ABL is from the Financial Services sector.

ABUS vs ABL - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	ABUS(COMPANY)	ABL(COMPANY)
Market Cap	$811M	$813M
Max Drawdown	92.96%	N/A
Sharpe Ratio	0.56	0.00
5Y Beta	0.90	N/A
Industry	Biotechnology	Insurance - Life
P/E Ratio	5.06	20.47
Forward P/E	10.25	10.57
PEG Ratio	0.00	N/A
Debt to Equity	0.00%	79.02%
Free Cash Flow Yield	-4.23%	15.59%
P/S Ratio	4.34	N/A
P/B Ratio	3.23	N/A

Market Cap

ABUS

$811M

Winner

ABL

$813M

Max Drawdown

ABUS

92.96%

ABL

N/A

Sharpe Ratio

Winner

ABUS

0.56

ABL

0.00

5Y Beta

ABUS

0.90

ABL

N/A

Industry

ABUS

Biotechnology

ABL

Insurance - Life

P/E Ratio

Winner

ABUS

5.06

ABL

20.47

Forward P/E

Winner

ABUS

10.25

ABL

10.57

PEG Ratio

ABUS

0.00

ABL

N/A

Debt to Equity

Winner

ABUS

0.00%

ABL

79.02%

Free Cash Flow Yield

ABUS

-4.23%

Winner

ABL

15.59%

P/S Ratio

ABUS

4.34

ABL

N/A

P/B Ratio

ABUS

3.23

ABL

N/A

ABUS vs ABL - Historical Returns

Returns include dividend reinvestment.

Period	ABUS	ABL
1 month	-1.16%	N/A
3 months	-1.39%	N/A
6 months	-9.55%	N/A
1 year	+18.99%	N/A
5 years(CAGR)	+5.37%	N/A
10 years(CAGR)	+2.40%	N/A
Max(CAGR)	-7.97%	+0.00%

ABUS

-1.16%

ABL

N/A

ABUS

-1.39%

ABL

N/A

ABUS

-9.55%

ABL

N/A

ABUS

+18.99%

ABL

N/A

5Y(CAGR)

ABUS

+5.37%

ABL

N/A

10Y(CAGR)

ABUS

+2.40%

ABL

N/A

Max(CAGR)

ABUS

-7.97%

Winner

ABL

+0.00%

ABUS vs ABL - Annual Returns (2015 - 2026)

Returns include dividend reinvestment.

Year	ABUS	ABL
2026	-10.69%	+0.00%
2025	+46.20%	N/A
2024	+26.25%	N/A
2023	+12.11%	N/A
2022	-41.46%	N/A
2021	+6.87%	N/A
2020	+20.75%	N/A
2019	-30.50%	N/A
2018	-29.72%	N/A
2017	+102.00%	N/A
2016	-45.80%	N/A
2015	-57.62%	N/A